Shares of Trillium Therapeutics (NASDAQ: TRIL) skyrocketed last year. After selling for $1.17 on the first trade in January, the shares clocked out at $14.71 on the last trade in December. This amazing run made Trillium a 13-bagger, and one of the strongest performers in the healthcare space in 2020. What caused this magnificent run?
In this clip from Motley Fool Live , healthcare and cannabis bureau chief Corinne Cardina and Fool.com contributor Taylor Carmichael discuss Trillium. The segment was recorded on Jan. 15, 2021.
For further details see:
Why the market Is So Bullish About Trillium Therapeutics